Net Income

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

Bitwise appoints a new data VP amid a frenzied AI market. But can one leader bridge the gap between massive spending and measurable business results?

A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.

Booking data reveals a shift in luxury travel towards privacy and curated experiences, forcing a supply chain evolution for those who cater to the elite.

While official data points to growth, new metrics reveal nearly 25% of workers are functionally unemployed, exposing a deep affordability crisis.

A promising fintech's complex arbitrage strategy collapses, triggering a stock crash, CEO exit, and a wave of securities fraud investigations.

SoftBank's move to delist French robotics firm BALYO offers a premium to shareholders but signals a larger consolidation in the automated logistics space.

MicroCloud Hologram is betting $400M on a quantum-driven 3D model. Is it a revolutionary leap for digital creation or a costly gamble on unproven tech?

Beyond a massive cookie giveaway, Dirty Dough is engineering loyalty and fueling franchise growth. Here's the strategy behind their 'Free for Life' campaign.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

Beyond the award, we explore Diebold Nixdorf's ESG data, the rise of corporate responsibility rankings, and why sustainability is now core business strategy.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

A landmark deal between a defense giant and a tech titan is set to revolutionize space operations. Here's why the future of national security is in the cloud.

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.

Canada's top tire distributor is restructuring for global conquest. A deep dive into the new Touchette Corporation, the leaders driving it, and its M&A ambitions.

A major CRO presents 10 pivotal studies at the world's top blood disease meeting, revealing a strategy built on real-world data and collaborative innovation.

Lion Group is diversifying its crypto-heavy treasury with Bitcoin. Is this a savvy move in a cool market or a high-stakes bet for a volatile company?

SkinSpirit's new Princeton clinic isn't just an expansion; it's a strategic move in the booming medical aesthetics market. Here's why it matters.

Amid soaring uranium prices, Foremost Clean Energy deploys advanced geophysics in the Athabasca Basin. A deep dive into the strategy behind the search.